JanetTobianMD

PubMed

• 20 citations
  Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2
  Mark Warren, Bruce W. Bode, Jang Ik Cho, Rong Liu, Janet Tobian, Thomas Hardy, Farai Chigutsa, Moshe Phillip, Barry Horowitz, Debra A. Ignaut> ;Diabetes, Obesity & Metabolism. 2021 Jul 1
• 6 citations
  Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension
  Juliana M. Bue-Valleskey, Leslie J. Klaff, Jang Ik Cho, Mary Anne Dellva, Nanette C. Schloot, Janet Tobian, Junnosuke Miura, Dominik Dahl> ;Diabetes Therapy. 2021 Jan 17
• 50 citations
  Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study.
  Leslie J. Klaff, Dachuang Cao, Mary Anne Dellva, Janet Tobian, Junnosuke Miura, Dominik Dahl, Jean Lucas, Juliana M. Bue-Valleskey> ;Diabetes, Obesity & Metabolism. 2020 Oct 1
• 26 citations
  Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Plos Genetics. 2012 Aug 1
• 5 citations
  Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.
  Ernesto Ang, Mary K Lawrence, Cory R Heilmann, Jeffrey A. Ferguson, Janet Tobian, David M. Webb, Pierre-Yves Berclaz> ;Diabetes Technology & Therapeutics. 2009 Sep 22
• 13 citations
  Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.
  Jorge Luiz Gross, Masako Nakano, Gildred Colon-Vega, Ramon Ortiz-Carasquillo, Jeffrey A. Ferguson, Sandra Althouse, Janet Tobian, Pierre-Yves Berclaz, Zvonko Milicevic> ;Diabetes Technology & Therapeutics. 2009 Sep 22
• 11 citations
  Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial
  Satish K. Garg, Chantal Mathieu, Nadeem Rais, Haitao Gao, Janet Tobian, Jeffrey R. Gates, Jeffrey A. Ferguson, David M. Webb, Pierre-Yves Berclaz> ;Diabetes Technology & Therapeutics. 2009 Sep 1
• 3 citations
  The impact of diabetes and age on pulmonary function: data from the National Health and Nutrition Examination Survey.
  Pierre-Yves Berclaz, Haitao Gao, Janet Tobian, Diana L. Swanson, David M. Webb, Robert O. Crapo, Robert L. Jensen> ;Diabetes Research and Clinical Practice. 2009 Jan 1
• 17 citations
  The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic data.
  Douglas B. Muchmore, Bernard L. Silverman, Amparo de la Peña, Janet Tobian> ;Diabetes Technology & Therapeutics. 2007 Jun 11
• 94 citations
  Use of the Continuous Glucose Monitoring System to Guide Therapy in Patients With Insulin-Treated Diabetes: A Randomized Controlled Trial
  Robert J. Tanenberg, Bruce W. Bode, Wendy Lane, Claresa S. Levetan, Jorge H. Mestman, Anne Peters Harmel, Janet Tobian, Todd M. Gross, John J. Mastrototaro> ;Mayo Clinic Proceedings. 2004 Dec 1
• 428 citations
  The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
  Adam Gordois, Paul Anthony Scuffham, Arran Shearer, A Oglesby, Janet Ash Tobian> ;Diabetes Care. 2003 Jun 1
• 32 citations
  Multiple elements are required for expression of an intermediate filament gene
  Christina M. Sax, Francis X. Farrell, Janet A. Tobian, Zendra E. Zehner> ;Nucleic Acids Research. 1988 Aug 25
• Diabetes in African American women: the silent epidemic.
  McNabb, W., Quinn, M., Tobian, J.> ;Womens Health.
• Unique pathway of expression of an opal suppressor phosphoserine tRNA.
  Lee, B. J., de la Peña, P., Tobian, J. A., Zasloff, M., Hatfield, D.> ;Proc Natl Acad Sci U S A. 1987 Sep
• Join now to see all